Potential herd protection against <i>Plasmodium falciparum</i> infections conferred by mass antimalarial drug administrations.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 30990166.
- Also identified by DOI 10.7554/eLife.41023 and PMC identifier 6467567.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The global malaria burden has decreased over the last decade and many nations are attempting elimination. Asymptomatic malaria infections are not normally diagnosed or treated, posing a major hurdle for elimination efforts. One solution to this problem is mass drug administration (MDA), with success depending on adequate population participation. Here, we present a detailed spatial and temporal analysis of malaria episodes and asymptomatic infections in four villages undergoing MDA in Myanmar. In this study, individuals from neighborhoods with low MDA adherence had 2.85 times the odds of having a malaria episode post-MDA in comparison to those from high adherence neighborhoods, regardless of individual participation, suggesting a herd effect. High mosquito biting rates, living in a house with someone else with malaria, or having an asymptomatic malaria infection were also predictors of clinical episodes. Spatial clustering of non-adherence to MDA, even in villages with high overall participation, may frustrate elimination efforts.
Medical subject headings
- Antimalarials
- Malaria, Falciparum
- Mass Drug Administration
- Plasmodium falciparum
- Drug Monitoring